The subject of the public contract is the repeated delivery of medicinal products containing the active substance bimekizumab, meeting the requirements of the SKL. Immunosuppressive agents, bimekizumab
🔍 Key Information
📄
Tender Reference No.
102100564
📅
Publication Date
26 Oct 2026
💰
Estimated Value
CZK 28894769
🌐
Sector
N/A
📅
Deadline
27 Nov 2026
📝
Notice Type
Tenders
📍
Location
N/A
📑
Contract Duration
1 Month 1 Day
📁
Documents & Downloads
No documents found
🏷️ CPV
No CPV found
Need help with this bid?
Our bid experts can help you find, evaluate & win more tenders.
